HARMONY BIOSCIENCES OPENS APPLICATIONS FOR 2022 PROGRESS AT THE HEART PROGRAM

Program will award funding to select applications from non-profit organizations addressing disparities in rare neurological disease and sleep disorder communities PLYMOUTH MEETING, Pa., April 7, 2022 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a…

About the Author

has written 21729 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com